Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$36.43 - $49.4 $4.37 Million - $5.93 Million
-120,000 Reduced 80.0%
30,000 $1.19 Million
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $6.1 Million - $7.95 Million
150,000 New
150,000 $6.99 Million
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $19.5 Million - $37.1 Million
-477,037 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $27.2 Million - $41.8 Million
454,091 Added 1978.95%
477,037 $34.5 Million
Q4 2021

Feb 14, 2022

SELL
$81.07 - $121.29 $19.2 Million - $28.7 Million
-237,026 Reduced 91.17%
22,946 $1.86 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $57 Million - $93 Million
-558,788 Reduced 68.25%
259,972 $30.3 Million
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $935,409 - $1.18 Million
6,606 Added 0.81%
818,760 $136 Million
Q1 2021

May 17, 2021

SELL
$132.81 - $182.18 $22 Million - $30.1 Million
-165,411 Reduced 16.92%
812,154 $113 Million
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $20.9 Million - $27.9 Million
151,401 Added 18.33%
977,565 $169 Million
Q3 2020

Nov 16, 2020

SELL
$114.09 - $145.51 $8.42 Million - $10.7 Million
-73,808 Reduced 8.2%
826,164 $115 Million
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $17.2 Million - $24.9 Million
-192,096 Reduced 17.59%
899,972 $108 Million
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $23 Million - $47.4 Million
328,182 Added 42.96%
1,092,068 $107 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $16.1 Million - $24.8 Million
-210,887 Reduced 21.63%
763,886 $89.8 Million
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $10 Million - $14.8 Million
-162,992 Reduced 14.33%
974,773 $83.8 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $41.8 Million - $48.3 Million
720,816 Added 172.88%
1,137,765 $73.8 Million
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $14.8 Million - $26.1 Million
416,949 New
416,949 $26.1 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.